Q1 FY2026 · ended Jul 31, 2026 · Revenue $30.97M, +59.9% YoY · Filed Sep 14, 2026
Kestra Medical Technologies, Ltd. (KMTS) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q1 of fiscal 2026, the quarter ended Jul 31, 2026, it reported revenue of $31.0 million and a net loss of $44.1 million. Free cash flow was -$40.6 million. As of Jul 31, 2026 it held $244.7 million in cash and investments and $76.4 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- KMTS (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- Bermuda
- Headquarters
- Kirkland, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1877184
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2026 Jul 31, 2026 |
Q4 FY2026 Apr 30, 2026 |
Q3 FY2026 Jan 31, 2026 |
Q2 FY2025 Oct 31, 2025 |
Q1 FY2025 Jul 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $31.0M | $28.6M | $24.6M | $22.6M | $19.4M |
| Operating income | -$37.7M | -$39.3M | -$34.8M | -$31.8M | -$28.9M |
| Net income | -$44.1M | -$38.8M | -$34.2M | -$32.8M | -$25.8M |
| Diluted EPS | -$0.75 | -$0.67 | -$0.61 | -$0.64 | -$0.50 |
| Operating cash flow | -$32.3M | -$18.7M | -$63.0M | -$18.3M | -$26.3M |
| Free cash flow | -$40.6M | -$28.4M | -$88.2M | -$25.6M | -$34.4M |
| Total assets | $347.4M | $358.5M | $379.3M | $246.7M | $266.3M |
| Total liabilities | $125.0M | $98.8M | $91.4M | $82.6M | $82.1M |
| Stockholders' equity | $222.4M | $259.7M | $288.0M | $164.1M | $184.2M |
| Cash and investments | $244.7M | $262.2M | $291.3M | $175.4M | $201.2M |
| Total debt | $76.4M | $46.8M | $46.5M | $44.8M | $44.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Sep 14, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 10, 2026 | Sep 9, 2026 |
| ARS | Annual report to shareholders | Jul 28, 2026 | Apr 30, 2026 |
| 10-K | Annual report | Jul 14, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, New debt
|
Jul 14, 2026 | Jul 10, 2026 |
All 186 Kestra Medical Technologies, Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.